Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 247 | 2025 | 6267 | 14.500 |
Why?
|
Anti-Asthmatic Agents | 59 | 2025 | 572 | 10.290 |
Why?
|
Bronchodilator Agents | 36 | 2024 | 513 | 4.640 |
Why?
|
Adrenal Cortex Hormones | 67 | 2025 | 1884 | 4.610 |
Why?
|
Albuterol | 25 | 2024 | 211 | 2.740 |
Why?
|
Administration, Inhalation | 61 | 2025 | 1154 | 2.210 |
Why?
|
Eosinophils | 30 | 2024 | 952 | 1.890 |
Why?
|
Glucocorticoids | 19 | 2023 | 2158 | 1.850 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 8 | 2019 | 109 | 1.750 |
Why?
|
Adrenergic beta-Agonists | 16 | 2025 | 345 | 1.750 |
Why?
|
Beclomethasone | 16 | 2022 | 38 | 1.700 |
Why?
|
Sputum | 19 | 2025 | 513 | 1.550 |
Why?
|
Forced Expiratory Volume | 41 | 2023 | 1828 | 1.390 |
Why?
|
Receptors, Adrenergic, beta-2 | 9 | 2019 | 216 | 1.370 |
Why?
|
Biological Products | 4 | 2024 | 948 | 1.330 |
Why?
|
Bronchi | 13 | 2021 | 847 | 1.280 |
Why?
|
Breath Tests | 12 | 2023 | 297 | 1.260 |
Why?
|
Nebulizers and Vaporizers | 6 | 2024 | 138 | 1.250 |
Why?
|
Budesonide | 10 | 2024 | 162 | 1.150 |
Why?
|
Leukotriene Antagonists | 10 | 2016 | 124 | 1.110 |
Why?
|
Pharmacogenetics | 7 | 2012 | 682 | 1.100 |
Why?
|
Interleukin-5 | 5 | 2024 | 268 | 1.000 |
Why?
|
Pulmonary Eosinophilia | 2 | 2021 | 78 | 0.910 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2019 | 1236 | 0.850 |
Why?
|
Exhalation | 4 | 2013 | 185 | 0.820 |
Why?
|
Acetates | 6 | 2018 | 314 | 0.820 |
Why?
|
Adult | 170 | 2025 | 223253 | 0.780 |
Why?
|
Asthma, Exercise-Induced | 3 | 2013 | 23 | 0.780 |
Why?
|
Propranolol | 2 | 2014 | 493 | 0.770 |
Why?
|
Lung | 27 | 2024 | 10064 | 0.760 |
Why?
|
Mucus | 5 | 2024 | 346 | 0.740 |
Why?
|
Respiratory Sounds | 3 | 2021 | 702 | 0.730 |
Why?
|
Eosinophilia | 8 | 2024 | 554 | 0.710 |
Why?
|
Respiratory Function Tests | 20 | 2024 | 1691 | 0.700 |
Why?
|
Interleukin-13 | 5 | 2024 | 391 | 0.700 |
Why?
|
Double-Blind Method | 40 | 2024 | 12423 | 0.680 |
Why?
|
Humans | 271 | 2025 | 766432 | 0.670 |
Why?
|
Respiratory Mechanics | 3 | 2015 | 719 | 0.670 |
Why?
|
Respiratory Mucosa | 7 | 2024 | 437 | 0.660 |
Why?
|
Mast Cells | 6 | 2018 | 1405 | 0.660 |
Why?
|
Lipoxins | 6 | 2014 | 419 | 0.650 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 11 | 2022 | 3245 | 0.640 |
Why?
|
Severity of Illness Index | 36 | 2021 | 15897 | 0.620 |
Why?
|
Asthma, Aspirin-Induced | 5 | 2023 | 204 | 0.620 |
Why?
|
Nitric Oxide | 13 | 2023 | 2141 | 0.620 |
Why?
|
Disease Progression | 19 | 2024 | 13632 | 0.600 |
Why?
|
Quinolines | 5 | 2018 | 769 | 0.580 |
Why?
|
Drug Therapy, Combination | 16 | 2025 | 6306 | 0.570 |
Why?
|
Scopolamine Derivatives | 5 | 2015 | 23 | 0.550 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2017 | 347 | 0.530 |
Why?
|
Receptors, Leukotriene | 3 | 2019 | 97 | 0.510 |
Why?
|
Middle Aged | 117 | 2025 | 223127 | 0.510 |
Why?
|
Male | 163 | 2025 | 363975 | 0.490 |
Why?
|
Ankyrin Repeat | 1 | 2015 | 19 | 0.490 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 829 | 0.490 |
Why?
|
Metered Dose Inhalers | 5 | 2023 | 28 | 0.490 |
Why?
|
Bronchoconstriction | 4 | 2010 | 141 | 0.480 |
Why?
|
Antibodies, Monoclonal | 10 | 2024 | 9243 | 0.480 |
Why?
|
Polymorphism, Single Nucleotide | 19 | 2022 | 16042 | 0.470 |
Why?
|
Leukotriene B4 | 2 | 2013 | 281 | 0.470 |
Why?
|
Female | 164 | 2025 | 396354 | 0.460 |
Why?
|
Immunoglobulin E | 12 | 2024 | 1495 | 0.450 |
Why?
|
Drug Combinations | 6 | 2024 | 2078 | 0.450 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 178 | 0.450 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2015 | 313 | 0.450 |
Why?
|
Androstadienes | 9 | 2015 | 348 | 0.450 |
Why?
|
Particle Size | 9 | 2018 | 1634 | 0.440 |
Why?
|
Hypersensitivity, Immediate | 3 | 2023 | 348 | 0.420 |
Why?
|
Bronchial Hyperreactivity | 6 | 2017 | 299 | 0.410 |
Why?
|
Self Report | 4 | 2023 | 3770 | 0.410 |
Why?
|
Bronchial Provocation Tests | 6 | 2019 | 215 | 0.400 |
Why?
|
Phenotype | 25 | 2023 | 16721 | 0.390 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2025 | 10379 | 0.390 |
Why?
|
Drug Tolerance | 1 | 2013 | 365 | 0.390 |
Why?
|
Airway Remodeling | 4 | 2021 | 134 | 0.380 |
Why?
|
Pharmacokinetics | 1 | 2011 | 86 | 0.370 |
Why?
|
Quality of Life | 18 | 2025 | 13472 | 0.370 |
Why?
|
Genome-Wide Association Study | 11 | 2023 | 12807 | 0.360 |
Why?
|
Spirometry | 7 | 2022 | 929 | 0.350 |
Why?
|
Pulmonary Medicine | 2 | 2013 | 223 | 0.350 |
Why?
|
Young Adult | 47 | 2024 | 59928 | 0.340 |
Why?
|
Saline Solution, Hypertonic | 1 | 2010 | 116 | 0.340 |
Why?
|
Interleukin-6 | 5 | 2021 | 3226 | 0.340 |
Why?
|
Adolescent | 59 | 2024 | 88898 | 0.340 |
Why?
|
Obesity | 13 | 2024 | 13088 | 0.340 |
Why?
|
Child | 49 | 2024 | 80668 | 0.340 |
Why?
|
Medication Adherence | 3 | 2023 | 2189 | 0.330 |
Why?
|
Patient Care Planning | 1 | 2015 | 903 | 0.330 |
Why?
|
Anti-Inflammatory Agents | 3 | 2017 | 1805 | 0.330 |
Why?
|
Eosinophil Peroxidase | 3 | 2024 | 22 | 0.320 |
Why?
|
Leukocyte Count | 10 | 2024 | 1606 | 0.310 |
Why?
|
Inflammation | 16 | 2024 | 10860 | 0.300 |
Why?
|
Alendronate | 2 | 2019 | 174 | 0.290 |
Why?
|
Morbidity | 5 | 2023 | 1753 | 0.290 |
Why?
|
Allergens | 7 | 2021 | 1436 | 0.280 |
Why?
|
Cysteine | 2 | 2018 | 898 | 0.280 |
Why?
|
Mucin 5AC | 2 | 2024 | 96 | 0.280 |
Why?
|
Cholecalciferol | 3 | 2018 | 550 | 0.280 |
Why?
|
Tryptases | 2 | 2018 | 175 | 0.270 |
Why?
|
Insulin Resistance | 2 | 2022 | 3989 | 0.270 |
Why?
|
Social Class | 3 | 2022 | 2006 | 0.270 |
Why?
|
Treatment Failure | 7 | 2021 | 2653 | 0.270 |
Why?
|
Epithelial Cells | 8 | 2024 | 3689 | 0.260 |
Why?
|
Genotype | 14 | 2020 | 13034 | 0.260 |
Why?
|
Bronchoalveolar Lavage Fluid | 8 | 2024 | 755 | 0.260 |
Why?
|
Polymorphism, Genetic | 7 | 2024 | 4249 | 0.250 |
Why?
|
Patient Preference | 2 | 2023 | 947 | 0.250 |
Why?
|
Treatment Outcome | 37 | 2024 | 65202 | 0.250 |
Why?
|
Cytokines | 8 | 2024 | 7436 | 0.250 |
Why?
|
Th2 Cells | 3 | 2020 | 1078 | 0.240 |
Why?
|
Cross-Over Studies | 12 | 2019 | 2108 | 0.240 |
Why?
|
Puerto Rico | 2 | 2023 | 380 | 0.230 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2019 | 10740 | 0.230 |
Why?
|
Leukotrienes | 3 | 2013 | 232 | 0.230 |
Why?
|
Cardiac Tamponade | 1 | 2005 | 173 | 0.220 |
Why?
|
Methacholine Chloride | 5 | 2019 | 219 | 0.220 |
Why?
|
Pulmonary Artery | 2 | 2019 | 1938 | 0.220 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2005 | 216 | 0.220 |
Why?
|
Vital Capacity | 6 | 2021 | 995 | 0.220 |
Why?
|
Deoxyribonuclease I | 1 | 2024 | 228 | 0.210 |
Why?
|
Common Cold | 1 | 2023 | 63 | 0.210 |
Why?
|
Aged | 44 | 2024 | 171234 | 0.210 |
Why?
|
Bronchoscopy | 6 | 2024 | 913 | 0.210 |
Why?
|
Registries | 1 | 2019 | 8344 | 0.210 |
Why?
|
Uteroglobin | 1 | 2023 | 55 | 0.210 |
Why?
|
Cohort Studies | 24 | 2021 | 41703 | 0.210 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 472 | 0.200 |
Why?
|
Cholinergic Antagonists | 2 | 2015 | 165 | 0.200 |
Why?
|
Sulfides | 5 | 2018 | 169 | 0.200 |
Why?
|
Chemokine CCL5 | 1 | 2023 | 214 | 0.200 |
Why?
|
Lectins | 1 | 2024 | 490 | 0.200 |
Why?
|
RGS Proteins | 1 | 2022 | 76 | 0.200 |
Why?
|
Rodent Control | 1 | 2021 | 15 | 0.190 |
Why?
|
Triamcinolone | 3 | 2019 | 68 | 0.190 |
Why?
|
Triamcinolone Acetonide | 2 | 2003 | 105 | 0.190 |
Why?
|
Cyclopropanes | 5 | 2018 | 436 | 0.190 |
Why?
|
Aged, 80 and over | 18 | 2024 | 59538 | 0.190 |
Why?
|
Inflammasomes | 2 | 2019 | 541 | 0.190 |
Why?
|
Aspirin | 5 | 2023 | 3134 | 0.190 |
Why?
|
Models, Genetic | 1 | 2011 | 3450 | 0.190 |
Why?
|
Muscarinic Antagonists | 1 | 2022 | 135 | 0.190 |
Why?
|
Respiratory System | 2 | 2018 | 562 | 0.180 |
Why?
|
Respiratory Hypersensitivity | 1 | 2023 | 271 | 0.180 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 395 | 0.180 |
Why?
|
Penicillium chrysogenum | 1 | 2020 | 7 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5696 | 0.180 |
Why?
|
Docosahexaenoic Acids | 2 | 2023 | 915 | 0.180 |
Why?
|
Peak Expiratory Flow Rate | 6 | 2018 | 143 | 0.180 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2021 | 240 | 0.180 |
Why?
|
Prostaglandins | 3 | 2023 | 398 | 0.180 |
Why?
|
Progesterone Reductase | 1 | 2020 | 14 | 0.170 |
Why?
|
Steroid Isomerases | 1 | 2020 | 19 | 0.170 |
Why?
|
Sex Factors | 7 | 2021 | 10614 | 0.170 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 2 | 2018 | 75 | 0.170 |
Why?
|
Fish Oils | 1 | 2003 | 483 | 0.170 |
Why?
|
Respiratory Tract Infections | 2 | 2019 | 1008 | 0.170 |
Why?
|
Environmental Exposure | 5 | 2021 | 4544 | 0.170 |
Why?
|
Steroids | 1 | 2024 | 936 | 0.160 |
Why?
|
Research Design | 5 | 2021 | 6205 | 0.160 |
Why?
|
Air Pollution, Indoor | 2 | 2021 | 930 | 0.160 |
Why?
|
Granulocytes | 1 | 2021 | 551 | 0.160 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 452 | 0.160 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 158 | 0.160 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2020 | 418 | 0.160 |
Why?
|
Ipratropium | 1 | 2018 | 19 | 0.160 |
Why?
|
Virus Diseases | 1 | 2025 | 720 | 0.160 |
Why?
|
Remission Induction | 1 | 2024 | 2413 | 0.150 |
Why?
|
Moraxella | 1 | 2018 | 25 | 0.150 |
Why?
|
Behavior | 1 | 2021 | 538 | 0.150 |
Why?
|
Corynebacterium | 1 | 2018 | 49 | 0.150 |
Why?
|
Aerosols | 2 | 2018 | 634 | 0.150 |
Why?
|
Patient Selection | 2 | 2021 | 4248 | 0.150 |
Why?
|
Smoking | 6 | 2021 | 9076 | 0.150 |
Why?
|
Cell Count | 4 | 2017 | 1826 | 0.150 |
Why?
|
Pregnenediones | 2 | 2016 | 29 | 0.150 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7426 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 155 | 0.150 |
Why?
|
Prostaglandin D2 | 2 | 2015 | 109 | 0.150 |
Why?
|
Muscle Stretching Exercises | 1 | 2018 | 37 | 0.150 |
Why?
|
Patient Acceptance of Health Care | 4 | 2023 | 3230 | 0.150 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 117 | 0.140 |
Why?
|
Neutrophils | 6 | 2023 | 3782 | 0.140 |
Why?
|
Serpins | 1 | 2019 | 245 | 0.140 |
Why?
|
Vitamin D Deficiency | 3 | 2018 | 1348 | 0.140 |
Why?
|
Schools | 2 | 2021 | 1495 | 0.140 |
Why?
|
Sports | 1 | 2003 | 703 | 0.140 |
Why?
|
Inhalation Spacers | 1 | 2017 | 4 | 0.140 |
Why?
|
Longitudinal Studies | 8 | 2023 | 14760 | 0.140 |
Why?
|
Mouth | 1 | 2020 | 383 | 0.140 |
Why?
|
Drug Administration Schedule | 6 | 2015 | 4850 | 0.140 |
Why?
|
Sinusitis | 3 | 2023 | 997 | 0.140 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3601 | 0.140 |
Why?
|
Arginine | 2 | 2012 | 932 | 0.140 |
Why?
|
Databases, Factual | 4 | 2016 | 8061 | 0.140 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2017 | 273 | 0.130 |
Why?
|
Multienzyme Complexes | 1 | 2020 | 663 | 0.130 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2825 | 0.130 |
Why?
|
United States | 18 | 2023 | 72910 | 0.130 |
Why?
|
Age of Onset | 6 | 2014 | 3342 | 0.130 |
Why?
|
Waist Circumference | 2 | 2018 | 934 | 0.130 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 285 | 0.130 |
Why?
|
Airway Obstruction | 2 | 2018 | 672 | 0.120 |
Why?
|
Disease Management | 3 | 2023 | 2530 | 0.120 |
Why?
|
Resistance Training | 1 | 2018 | 197 | 0.120 |
Why?
|
Interleukins | 2 | 2017 | 794 | 0.120 |
Why?
|
Lymphocytes | 2 | 2013 | 2605 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1120 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 583 | 0.120 |
Why?
|
Tosyl Compounds | 2 | 2005 | 115 | 0.120 |
Why?
|
Ibuprofen | 1 | 2016 | 228 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2023 | 12788 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1089 | 0.120 |
Why?
|
Airway Resistance | 2 | 2007 | 407 | 0.120 |
Why?
|
Drug Resistance | 2 | 2020 | 1591 | 0.120 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2019 | 580 | 0.120 |
Why?
|
Forced Expiratory Flow Rates | 3 | 2015 | 76 | 0.110 |
Why?
|
Azithromycin | 1 | 2015 | 201 | 0.110 |
Why?
|
Thromboplastin | 1 | 2016 | 289 | 0.110 |
Why?
|
Cell Shape | 1 | 2015 | 372 | 0.110 |
Why?
|
Echium | 1 | 2013 | 3 | 0.110 |
Why?
|
Child, Preschool | 15 | 2022 | 42576 | 0.110 |
Why?
|
gamma-Linolenic Acid | 1 | 2013 | 16 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 706 | 0.110 |
Why?
|
Epoxide Hydrolases | 1 | 2014 | 122 | 0.110 |
Why?
|
Biomedical Research | 4 | 2013 | 3458 | 0.110 |
Why?
|
Drug Hypersensitivity | 2 | 2019 | 903 | 0.110 |
Why?
|
Gastroesophageal Reflux | 2 | 2011 | 834 | 0.110 |
Why?
|
Minority Groups | 1 | 2021 | 1208 | 0.110 |
Why?
|
Prospective Studies | 13 | 2023 | 54826 | 0.110 |
Why?
|
Integrin beta Chains | 1 | 2013 | 116 | 0.110 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2013 | 39 | 0.110 |
Why?
|
Hypertriglyceridemia | 1 | 2016 | 292 | 0.100 |
Why?
|
Dietary Supplements | 2 | 2018 | 3428 | 0.100 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2019 | 1896 | 0.100 |
Why?
|
Genetic Markers | 2 | 2013 | 2603 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3508 | 0.100 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1284 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2016 | 2747 | 0.100 |
Why?
|
Lung Volume Measurements | 3 | 2019 | 381 | 0.100 |
Why?
|
Plant Oils | 1 | 2013 | 199 | 0.100 |
Why?
|
Blood Vessels | 1 | 2018 | 1111 | 0.100 |
Why?
|
Pneumonia | 3 | 2017 | 2159 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2022 | 7840 | 0.100 |
Why?
|
Clinical Competence | 1 | 2008 | 4858 | 0.100 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2012 | 86 | 0.100 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2013 | 165 | 0.100 |
Why?
|
Acetaminophen | 1 | 2016 | 549 | 0.100 |
Why?
|
Self Care | 1 | 2017 | 800 | 0.100 |
Why?
|
Microspheres | 1 | 2015 | 774 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1560 | 0.100 |
Why?
|
Pilot Projects | 4 | 2020 | 8720 | 0.100 |
Why?
|
Hospitalization | 5 | 2021 | 10812 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 206 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2041 | 0.100 |
Why?
|
Lung Diseases | 1 | 2022 | 1941 | 0.090 |
Why?
|
ADAM Proteins | 1 | 2013 | 243 | 0.090 |
Why?
|
Sleep | 2 | 2021 | 4815 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 966 | 0.090 |
Why?
|
Menstruation | 1 | 2013 | 310 | 0.090 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1394 | 0.090 |
Why?
|
Thrombosis | 1 | 2005 | 2950 | 0.090 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2011 | 97 | 0.090 |
Why?
|
Case-Control Studies | 11 | 2021 | 22245 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2012 | 18075 | 0.090 |
Why?
|
Carrier Proteins | 3 | 2014 | 4924 | 0.090 |
Why?
|
Logistic Models | 9 | 2019 | 13276 | 0.090 |
Why?
|
Gene Frequency | 3 | 2015 | 3624 | 0.090 |
Why?
|
Macrolides | 1 | 2012 | 204 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20706 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2012 | 370 | 0.090 |
Why?
|
Pandemics | 2 | 2022 | 8729 | 0.090 |
Why?
|
Immunization | 2 | 2018 | 1218 | 0.090 |
Why?
|
Muscle, Smooth | 1 | 2015 | 931 | 0.090 |
Why?
|
Single-Blind Method | 3 | 2021 | 1587 | 0.090 |
Why?
|
Epithelium | 1 | 2015 | 1606 | 0.090 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 26294 | 0.090 |
Why?
|
Nitrogen Oxides | 1 | 2010 | 128 | 0.090 |
Why?
|
Body Mass Index | 6 | 2024 | 13045 | 0.090 |
Why?
|
Clarithromycin | 1 | 2010 | 87 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2017 | 1539 | 0.090 |
Why?
|
Age Factors | 9 | 2018 | 18395 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2592 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 713 | 0.080 |
Why?
|
Injections, Subcutaneous | 2 | 2021 | 684 | 0.080 |
Why?
|
Churg-Strauss Syndrome | 1 | 2010 | 75 | 0.080 |
Why?
|
Comorbidity | 4 | 2020 | 10579 | 0.080 |
Why?
|
5' Untranslated Regions | 1 | 2011 | 255 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2270 | 0.080 |
Why?
|
Bronchoalveolar Lavage | 2 | 2024 | 131 | 0.080 |
Why?
|
Bone Density | 2 | 2003 | 3491 | 0.080 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.080 |
Why?
|
Placebos | 2 | 2011 | 1659 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1468 | 0.080 |
Why?
|
Interferon-beta | 1 | 2011 | 348 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2477 | 0.080 |
Why?
|
Arachidonic Acid | 1 | 2010 | 430 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1168 | 0.080 |
Why?
|
Chemokines | 2 | 2024 | 962 | 0.080 |
Why?
|
Electrocoagulation | 1 | 2009 | 156 | 0.080 |
Why?
|
Exercise Test | 2 | 2013 | 2185 | 0.080 |
Why?
|
Ethanolamines | 2 | 2022 | 152 | 0.080 |
Why?
|
Risk Factors | 9 | 2021 | 74828 | 0.080 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1735 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5302 | 0.080 |
Why?
|
Mice | 14 | 2023 | 81863 | 0.080 |
Why?
|
Skin Tests | 5 | 2010 | 630 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1404 | 0.080 |
Why?
|
Income | 1 | 2017 | 1875 | 0.080 |
Why?
|
Bronchoconstrictor Agents | 3 | 2019 | 77 | 0.070 |
Why?
|
Genetic Variation | 6 | 2021 | 6612 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2013 | 744 | 0.070 |
Why?
|
Receptors, Lipoxin | 1 | 2008 | 83 | 0.070 |
Why?
|
Arginase | 1 | 2008 | 81 | 0.070 |
Why?
|
Th1 Cells | 1 | 2013 | 1040 | 0.070 |
Why?
|
Receptors, Formyl Peptide | 1 | 2008 | 146 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2011 | 582 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 413 | 0.070 |
Why?
|
Interleukin-17 | 1 | 2013 | 923 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1109 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1389 | 0.070 |
Why?
|
Placebo Effect | 1 | 2011 | 515 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2019 | 3821 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4879 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2210 | 0.070 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 741 | 0.070 |
Why?
|
Acupuncture Therapy | 1 | 2011 | 467 | 0.070 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2016 | 1104 | 0.070 |
Why?
|
Prevalence | 5 | 2016 | 15820 | 0.070 |
Why?
|
Nasal Polyps | 3 | 2018 | 412 | 0.070 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 57 | 0.070 |
Why?
|
Gene Expression | 5 | 2021 | 7583 | 0.070 |
Why?
|
Membrane Proteins | 3 | 2013 | 7866 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6327 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2015 | 7475 | 0.070 |
Why?
|
Estradiol | 1 | 2014 | 1947 | 0.070 |
Why?
|
Quantitative Trait Loci | 3 | 2021 | 2135 | 0.070 |
Why?
|
Specimen Handling | 1 | 2010 | 706 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1326 | 0.060 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 319 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3110 | 0.060 |
Why?
|
Vitamins | 1 | 2014 | 1630 | 0.060 |
Why?
|
Prednisone | 2 | 2012 | 1566 | 0.060 |
Why?
|
DNA | 1 | 2019 | 7207 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3111 | 0.060 |
Why?
|
Administration, Oral | 4 | 2018 | 4014 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 828 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2005 | 243 | 0.060 |
Why?
|
Lactoperoxidase | 1 | 2024 | 5 | 0.060 |
Why?
|
Animals | 16 | 2023 | 168887 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2059 | 0.060 |
Why?
|
Polysomnography | 1 | 2011 | 1868 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1885 | 0.060 |
Why?
|
Acute Disease | 4 | 2019 | 7240 | 0.060 |
Why?
|
Family Practice | 1 | 2007 | 508 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2023 | 81588 | 0.060 |
Why?
|
Phospholipases A | 1 | 2005 | 204 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2671 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2714 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2019 | 18979 | 0.060 |
Why?
|
Antigens, Dermatophagoides | 2 | 2018 | 101 | 0.060 |
Why?
|
Housing | 1 | 2009 | 682 | 0.060 |
Why?
|
Hypersensitivity | 2 | 2010 | 1169 | 0.060 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 88 | 0.060 |
Why?
|
Proteomics | 2 | 2024 | 3906 | 0.050 |
Why?
|
Receptors, Thromboxane | 1 | 2023 | 30 | 0.050 |
Why?
|
Thromboxanes | 1 | 2023 | 45 | 0.050 |
Why?
|
Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3141 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2018 | 1044 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1083 | 0.050 |
Why?
|
Leukotriene E4 | 1 | 2023 | 75 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 8042 | 0.050 |
Why?
|
Gels | 1 | 2024 | 420 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2016 | 3159 | 0.050 |
Why?
|
Deoxyribonucleases | 1 | 2024 | 209 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20129 | 0.050 |
Why?
|
Indoles | 3 | 2005 | 1832 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1962 | 0.050 |
Why?
|
Leukotriene C4 | 1 | 2003 | 79 | 0.050 |
Why?
|
Cholecystokinin | 1 | 2023 | 114 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4031 | 0.050 |
Why?
|
Occupational Diseases | 1 | 2010 | 1456 | 0.050 |
Why?
|
Mucin-5B | 1 | 2023 | 148 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.050 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2003 | 128 | 0.050 |
Why?
|
Fluocinolone Acetonide | 1 | 2002 | 38 | 0.050 |
Why?
|
Signal Transduction | 5 | 2020 | 23611 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1463 | 0.050 |
Why?
|
Mice, Obese | 1 | 2023 | 417 | 0.050 |
Why?
|
Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6508 | 0.050 |
Why?
|
Receptors, Interleukin-4 | 1 | 2021 | 65 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2021 | 1437 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2024 | 591 | 0.050 |
Why?
|
Interleukin-2 | 1 | 2008 | 1894 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5535 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
Africa | 1 | 2023 | 726 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39283 | 0.050 |
Why?
|
Eicosanoids | 1 | 2023 | 284 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5789 | 0.050 |
Why?
|
Glucuronidase | 1 | 2022 | 205 | 0.050 |
Why?
|
Mucins | 1 | 2024 | 569 | 0.050 |
Why?
|
Odds Ratio | 4 | 2015 | 9654 | 0.050 |
Why?
|
Nasal Mucosa | 1 | 2024 | 416 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12061 | 0.040 |
Why?
|
Eosinophil-Derived Neurotoxin | 1 | 2020 | 13 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4566 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2005 | 1838 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4215 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2024 | 877 | 0.040 |
Why?
|
Histamine | 1 | 2022 | 496 | 0.040 |
Why?
|
Dinoprostone | 1 | 2023 | 597 | 0.040 |
Why?
|
Alleles | 3 | 2020 | 6894 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3702 | 0.040 |
Why?
|
Hypertension | 2 | 2020 | 8614 | 0.040 |
Why?
|
Proteins | 2 | 2012 | 6002 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2012 | 2249 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11919 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2021 | 513 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3241 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2002 | 957 | 0.040 |
Why?
|
Immunoblotting | 2 | 2014 | 1646 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2001 | 274 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 638 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2018 | 14466 | 0.040 |
Why?
|
Geography | 1 | 2021 | 651 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2019 | 2718 | 0.040 |
Why?
|
ROC Curve | 2 | 2005 | 3616 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2010 | 3068 | 0.040 |
Why?
|
Cats | 2 | 2010 | 972 | 0.040 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2019 | 209 | 0.040 |
Why?
|
Flow Cytometry | 3 | 2014 | 5890 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2019 | 514 | 0.040 |
Why?
|
Infant | 5 | 2022 | 36460 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 796 | 0.040 |
Why?
|
Oxidants | 1 | 2018 | 168 | 0.040 |
Why?
|
Premenopause | 1 | 2001 | 1039 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 325 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 129 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2017 | 1791 | 0.030 |
Why?
|
Age Distribution | 2 | 2015 | 2868 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2012 | 1996 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4559 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 296 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8725 | 0.030 |
Why?
|
Prostaglandins D | 1 | 2015 | 27 | 0.030 |
Why?
|
Growth | 1 | 2018 | 365 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2019 | 701 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9601 | 0.030 |
Why?
|
Elasticity | 1 | 2018 | 652 | 0.030 |
Why?
|
Phenylcarbamates | 2 | 2005 | 38 | 0.030 |
Why?
|
Air Pollutants | 1 | 2010 | 2921 | 0.030 |
Why?
|
Research Personnel | 1 | 2020 | 589 | 0.030 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7869 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2018 | 434 | 0.030 |
Why?
|
Headache | 1 | 2023 | 1260 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 447 | 0.030 |
Why?
|
Demography | 1 | 2020 | 1641 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3803 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2014 | 6212 | 0.030 |
Why?
|
Femur | 1 | 2001 | 1318 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2015 | 116 | 0.030 |
Why?
|
Puberty | 1 | 2018 | 495 | 0.030 |
Why?
|
RNA, Bacterial | 1 | 2016 | 393 | 0.030 |
Why?
|
Linear Models | 2 | 2018 | 5872 | 0.030 |
Why?
|
Nose | 1 | 2018 | 522 | 0.030 |
Why?
|
Dogs | 2 | 2010 | 3834 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2261 | 0.030 |
Why?
|
Immunotherapy | 1 | 2010 | 4749 | 0.030 |
Why?
|
Ovalbumin | 1 | 2016 | 676 | 0.030 |
Why?
|
Prognosis | 4 | 2021 | 29922 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4348 | 0.030 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 64 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8478 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1732 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2275 | 0.030 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2013 | 22 | 0.030 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2013 | 40 | 0.030 |
Why?
|
STAT4 Transcription Factor | 1 | 2013 | 94 | 0.030 |
Why?
|
Seeds | 1 | 2013 | 125 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 2 | 2013 | 1851 | 0.030 |
Why?
|
alpha-Linolenic Acid | 1 | 2013 | 145 | 0.030 |
Why?
|
Smoking Cessation | 2 | 2015 | 2082 | 0.030 |
Why?
|
Delivery of Health Care | 3 | 2020 | 5367 | 0.030 |
Why?
|
Adiposity | 1 | 2023 | 1892 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2022 | 3424 | 0.030 |
Why?
|
Bone and Bones | 1 | 2003 | 2559 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2038 | 0.030 |
Why?
|
Nuclear Pore | 1 | 2012 | 61 | 0.020 |
Why?
|
Androgens | 1 | 2020 | 1279 | 0.020 |
Why?
|
Hydrogels | 1 | 2018 | 729 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2001 | 1878 | 0.020 |
Why?
|
Naphthyridines | 1 | 2014 | 184 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12147 | 0.020 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.020 |
Why?
|
Homeostasis | 1 | 2023 | 3341 | 0.020 |
Why?
|
Exons | 1 | 2018 | 2392 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2272 | 0.020 |
Why?
|
Blotting, Western | 1 | 2019 | 5021 | 0.020 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2011 | 69 | 0.020 |
Why?
|
Biomarkers, Pharmacological | 1 | 2012 | 161 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2014 | 596 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1597 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15639 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2022 | 4779 | 0.020 |
Why?
|
Shoulder Joint | 1 | 2018 | 745 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15390 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2746 | 0.020 |
Why?
|
Societies, Medical | 1 | 2023 | 3953 | 0.020 |
Why?
|
Mycoplasma pneumoniae | 1 | 2010 | 43 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2304 | 0.020 |
Why?
|
Chlamydophila pneumoniae | 1 | 2010 | 53 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3427 | 0.020 |
Why?
|
Turkey | 1 | 2011 | 256 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2013 | 581 | 0.020 |
Why?
|
Down-Regulation | 2 | 2010 | 2930 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2013 | 539 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3481 | 0.020 |
Why?
|
Thrombospondins | 1 | 2011 | 197 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1672 | 0.020 |
Why?
|
Mites | 1 | 2010 | 46 | 0.020 |
Why?
|
Hospital Costs | 1 | 2016 | 955 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6061 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2013 | 22337 | 0.020 |
Why?
|
Time Factors | 3 | 2020 | 40116 | 0.020 |
Why?
|
Pollen | 1 | 2010 | 80 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 565 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1673 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2009 | 222 | 0.020 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 228 | 0.020 |
Why?
|
Bibliometrics | 1 | 2013 | 355 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1602 | 0.020 |
Why?
|
Cockroaches | 1 | 2009 | 92 | 0.020 |
Why?
|
Fever | 1 | 2016 | 1607 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2470 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4270 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3093 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2626 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 595 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2011 | 663 | 0.020 |
Why?
|
Editorial Policies | 1 | 2013 | 458 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 24272 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2015 | 1065 | 0.020 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2011 | 278 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2014 | 10438 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1997 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 701 | 0.020 |
Why?
|
Models, Biological | 2 | 2015 | 9458 | 0.020 |
Why?
|
Rhinitis | 1 | 2015 | 753 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1967 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4966 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2013 | 1026 | 0.020 |
Why?
|
Biological Availability | 1 | 2008 | 387 | 0.020 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 2008 | 225 | 0.020 |
Why?
|
London | 1 | 2007 | 233 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 306 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1697 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1562 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14643 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18322 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2599 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2011 | 733 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2011 | 751 | 0.020 |
Why?
|
Dust | 1 | 2009 | 489 | 0.020 |
Why?
|
Vasculitis | 1 | 2010 | 528 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2010 | 619 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 2005 | 164 | 0.020 |
Why?
|
Bacteria | 1 | 2016 | 2212 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1866 | 0.020 |
Why?
|
Sulfonamides | 2 | 2005 | 1978 | 0.020 |
Why?
|
Keto Acids | 1 | 2005 | 34 | 0.020 |
Why?
|
Annexins | 1 | 2004 | 40 | 0.020 |
Why?
|
Phospholipases A2 | 1 | 2005 | 197 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2430 | 0.010 |
Why?
|
Metabolomics | 1 | 2014 | 1675 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6217 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15563 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1398 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 661 | 0.010 |
Why?
|
Hydrocortisone | 2 | 2002 | 1838 | 0.010 |
Why?
|
Total Lung Capacity | 1 | 2004 | 148 | 0.010 |
Why?
|
Lung Compliance | 1 | 2004 | 207 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2799 | 0.010 |
Why?
|
Inhalation | 1 | 2004 | 142 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2004 | 425 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2920 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4410 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2215 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5883 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12412 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6259 | 0.010 |
Why?
|
Mutation | 2 | 2022 | 30220 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2038 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2815 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1528 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4671 | 0.010 |
Why?
|
Algorithms | 2 | 2017 | 14071 | 0.010 |
Why?
|
RNA | 1 | 2011 | 2715 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3681 | 0.010 |
Why?
|
Pain | 1 | 2016 | 5097 | 0.010 |
Why?
|
Software | 1 | 2015 | 4464 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2004 | 1155 | 0.010 |
Why?
|
Haplotypes | 1 | 2006 | 2727 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8300 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11059 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2008 | 10263 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30235 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2011 | 3078 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4521 | 0.010 |
Why?
|
Macrophages | 1 | 2013 | 5782 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21509 | 0.010 |
Why?
|
Glycoproteins | 1 | 2005 | 2201 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9507 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9333 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2475 | 0.010 |
Why?
|
Depression | 1 | 2016 | 8229 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 2495 | 0.010 |
Why?
|
Up-Regulation | 1 | 2004 | 4141 | 0.010 |
Why?
|
Patient Readmission | 1 | 2009 | 3282 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9611 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4913 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5502 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8536 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2003 | 2043 | 0.010 |
Why?
|
Primary Health Care | 1 | 2007 | 4734 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2009 | 15818 | 0.000 |
Why?
|
Chronic Disease | 1 | 2002 | 9352 | 0.000 |
Why?
|